{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05063162",
            "orgStudyIdInfo": {
                "id": "MOG001"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-000352-19",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "UCB Pharma",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)",
            "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)",
            "acronym": "cosMOG",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-the-efficacy-and-safety-of-rozanolixizumab-in-adult-participants-with-myelin-oligodendrocyte-glycoprotein-mog-antibody-associated-disease-mog-ad"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-02-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-21",
            "studyFirstSubmitQcDate": "2021-09-21",
            "studyFirstPostDateStruct": {
                "date": "2021-09-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-20",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "UCB Biopharma SRL",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD)."
        },
        "conditionsModule": {
            "conditions": [
                "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)"
            ],
            "keywords": [
                "MOG",
                "MOGAD",
                "Rozanolixizumab",
                "Myelin oligodendrocyte glycoprotein",
                "Myelin oligodendrocyte glycoprotein antibody-associated disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "maskingDescription": "MOG001 consists of a Double-Blind (Part A) and an Open-Label Extension Study Period (Part B).",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 104,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Rozanolixizumab Arm",
                    "type": "EXPERIMENTAL",
                    "description": "Participants randomized into this arm will receive rozanolixizumab at pre-specified timepoints.",
                    "interventionNames": [
                        "Drug: Rozanolixizumab"
                    ]
                },
                {
                    "label": "Placebo Arm",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants randomized into this arm will receive placebo at pre-specified timepoints to maintain the blinding.",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Rozanolixizumab",
                    "description": "* Pharmaceutical form: Solution for infusion\n* Route of administration: subcutaneous infusion\n\nParticipants will receive pre-specified doses of rozanolixizumab.",
                    "armGroupLabels": [
                        "Rozanolixizumab Arm"
                    ],
                    "otherNames": [
                        "UCB7665"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "* Pharmaceutical form: Solution for infusion\n* Route of administration: subcutaneous infusion\n\nParticipants will receive placebo.",
                    "armGroupLabels": [
                        "Placebo Arm"
                    ],
                    "otherNames": [
                        "PBO"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "For Part A: Time from randomization to first independently centrally adjudicated relapse (TTFR) during the DB Treatment Period",
                    "description": "The TTFR (days) will be defined as the interval between the date of randomization and the first date of the objective relapse.\n\nDuring the Double Blind (DB) Treatment Period (Part A); EDB/EWD = End of Double-Blind/Early Withdrawal Visit",
                    "timeFrame": "Baseline (Week 1) to EDB/EWD Visit (until a confirmed relapse or up to approximately 132 weeks)"
                },
                {
                    "measure": "For Part B: Incidence of treatment-emergent adverse events (TEAEs) during OLE Treatment Period",
                    "description": "An adverse event (AE) is any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of investigational medicinal product (IMP), whether or not considered related to the IMP. NOTE: An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of IMP.\n\nOpen-Label Extension (OLE) Treatment Period (Part B); EOS/EWD = End of Study/Early Withdrawal Visit.",
                    "timeFrame": "OLE Treatment Period (OLE Week 1) to EOS/EWD Visit (up to OLE Week 52)"
                },
                {
                    "measure": "For Part B: Incidence of treatment-emergent adverse events (TEAEs) leading to permanent withdrawal of investigational medicinal product (IMP) during OLE Treatment Period",
                    "description": "An adverse event (AE) is any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of investigational medicinal product (IMP), whether or not considered related to the IMP. NOTE: An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of IMP. TEAEs leading to discontinuation of the study are reported.\n\nDuring Part B.",
                    "timeFrame": "OLE Treatment Period (OLE Week 1) to EOS/EWD Visit (up to OLE Week 52)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "For Part A: Change from Baseline in Low-Contrast Monocular Visual Acuity (Worst Affected Eye) measured by low-contrast Landolt C Broken Rings Chart at the EDB/EWD Visit",
                    "description": "Visual acuity is a measurement of the capacity for visual discrimination of fine details. Visual acuity tests are used to determine the smallest characters that can be read on a standardized chart. The Landolt C Broken Ring Chart uses standardized incomplete rings or \"C\", which are positioned in any direction in the chart (up, down, left, right, and 45 degree positions in between). The participant has to be able to indicate where the break of the \"C\" is located, by describing the position or by giving gesture.\n\nDuring Part A.",
                    "timeFrame": "From Baseline (Week 1) to EDB/EWD Visit (until a confirmed relapse or up to approximately 132 weeks)"
                },
                {
                    "measure": "For Part A: Disability as assessed by Expanded Disability Status Scale (EDSS) scores at the EDB/EWD Visit (with confirmation at 3 months)",
                    "description": "The EDSS is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death) in half-point increments with half steps from 1.0 to 9.5. The higher the value the higher is the level of impairment and disability.\n\nDuring Part A.",
                    "timeFrame": "Baseline (Week 1), EDB/EWD Visit (until a confirmed relapse or up to approximately 132 weeks)"
                },
                {
                    "measure": "For Part A: Number of MOG-AD related inpatient hospitalizations during the DB Treatment Period",
                    "description": "The total number of MOG-AD related hospitalizations from Baseline through EDB/EWD Visit.\n\nDuring Part A.",
                    "timeFrame": "Baseline (Week 1) to EDB/EWD Visit (until a confirmed relapse or up to approximately 132 weeks)"
                },
                {
                    "measure": "For Part A: Incidence of treatment-emergent adverse events (TEAEs) during the DB Treatment Period",
                    "description": "An adverse event (AE) is any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of investigational medicinal product (IMP), whether or not considered related to the IMP. NOTE: An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of IMP.\n\nDuring Part A.",
                    "timeFrame": "Baseline (Week 1) to EDB/EWD Visit (until a confirmed relapse or up to approximately 132 weeks)"
                },
                {
                    "measure": "For Part B: Independently centrally adjudicated annualized relapse rate (ARR) during the DB and OLE Treatment Period",
                    "description": "An ARR will be calculated for each participant prior to randomization into the Double-Blind Treatment Period (based on available historical data), and 2 ARRs after randomization to study treatment: first for relapses occurring during the Double-Blind Treatment Period and the second for relapses occurring during the OLE Treatment Period. The relapse episodes for each participant will be recorded throughout the entire study.",
                    "timeFrame": "Baseline (Week 1) to EOS/EWD Visit (up to OLE Week 52)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant must be \u226518 to \u226489 years of age, at the time of signing the informed consent\n* Confirmed diagnosis of MOG-AD consistent with published diagnostic criteria for MOG-AD\n* Participant has history of relapsing MOG-AD with at least 1 documented relapse over the last 12 months and a documented positive serum MOG Ab test using a cell-based assay (CBA) within 6 months prior to randomization\n* Participant must be clinically stable at the time of the Screening Visit and during the Screening Period\n\nExclusion Criteria:\n\n* Participant has been diagnosed with a neurological autoimmune disease (including multiple sclerosis (MS) and aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD)), or a systemic autoimmune disease that in the opinion of the investigator can interfere with the safety of the participant\n* Participant has a clinically important active infection (including unresolved or not adequately treated infection) as assessed by the investigator, including participants with a serious infection within 6 weeks prior to the first dose of the investigational medicinal product (IMP)\n* Participant has a current or medical history of primary immunodeficiency\n* Participant tests positive for aquaporin-4 antibodies at Screening\n* Participant has a serum total IgG level \u2264 5.5g/L",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "89 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "UCB Cares",
                    "role": "CONTACT",
                    "phone": "1-844-599-2273 (USA)",
                    "email": "UCBCares@ucb.com"
                },
                {
                    "name": "UCB Cares",
                    "role": "CONTACT",
                    "phone": "001 844 599 2273",
                    "email": "UCBCares@ucb.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "UCB Cares",
                    "affiliation": "001 844 599 2273",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mog001 50297",
                    "status": "RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85259-5452",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "Mog001 50450",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "Mog001 50101",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Mog001 50553",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20057",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "Mog001 50342",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224-1865",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "Mog001 50472",
                    "status": "RECRUITING",
                    "city": "Peoria",
                    "state": "Illinois",
                    "zip": "61637",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.69365,
                        "lon": -89.58899
                    }
                },
                {
                    "facility": "Mog001 50074",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "Mog001 50552",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Mog001 50243",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114-3117",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Mog001 50104",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Mog001 50571",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Mog001 50568",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Mog001 50473",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84108",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Mog001 30022",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Mog001 30026",
                    "status": "RECRUITING",
                    "city": "Southport",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -27.96724,
                        "lon": 153.39796
                    }
                },
                {
                    "facility": "Mog001 40122",
                    "status": "RECRUITING",
                    "city": "Edegem",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.15662,
                        "lon": 4.44504
                    }
                },
                {
                    "facility": "Mog001 40185",
                    "status": "RECRUITING",
                    "city": "Gent",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "Mog001 60033",
                    "status": "RECRUITING",
                    "city": "Porto Alegre",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -30.03306,
                        "lon": -51.23
                    }
                },
                {
                    "facility": "Mog001 40195",
                    "status": "RECRUITING",
                    "city": "Hradec Kralove",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 50.20923,
                        "lon": 15.83277
                    }
                },
                {
                    "facility": "Mog001 40124",
                    "status": "RECRUITING",
                    "city": "Praha 2",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 50.08804,
                        "lon": 14.42076
                    }
                },
                {
                    "facility": "Mog001 40721",
                    "status": "RECRUITING",
                    "city": "Teplice",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 50.6404,
                        "lon": 13.82451
                    }
                },
                {
                    "facility": "Mog001 40657",
                    "status": "RECRUITING",
                    "city": "Bron Cedex",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.73333,
                        "lon": 4.91667
                    }
                },
                {
                    "facility": "Mog001 40422",
                    "status": "RECRUITING",
                    "city": "Caen",
                    "country": "France",
                    "geoPoint": {
                        "lat": 49.18585,
                        "lon": -0.35912
                    }
                },
                {
                    "facility": "Mog001 40130",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Mog001 40170",
                    "status": "RECRUITING",
                    "city": "Strasbourg",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.58392,
                        "lon": 7.74553
                    }
                },
                {
                    "facility": "Mog001 40659",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Mog001 40140",
                    "status": "RECRUITING",
                    "city": "G\u00f6ttingen",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.53443,
                        "lon": 9.93228
                    }
                },
                {
                    "facility": "Mog001 40577",
                    "status": "RECRUITING",
                    "city": "ULM",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.39841,
                        "lon": 9.99155
                    }
                },
                {
                    "facility": "Mog001 40146",
                    "status": "RECRUITING",
                    "city": "Pavia",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.19205,
                        "lon": 9.15917
                    }
                },
                {
                    "facility": "Mog001 40629",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Mog001 40646",
                    "status": "RECRUITING",
                    "city": "Verona",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.4299,
                        "lon": 10.98444
                    }
                },
                {
                    "facility": "Mog001 20225",
                    "status": "RECRUITING",
                    "city": "Bunkyo-ku",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.37517,
                        "lon": 139.92991
                    }
                },
                {
                    "facility": "Mog001 20068",
                    "status": "RECRUITING",
                    "city": "Chiba-shi",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.6,
                        "lon": 140.11667
                    }
                },
                {
                    "facility": "Mog001 20307",
                    "status": "RECRUITING",
                    "city": "Isehara",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.39932,
                        "lon": 139.31019
                    }
                },
                {
                    "facility": "Mog001 20143",
                    "status": "RECRUITING",
                    "city": "Kodaira",
                    "country": "Japan"
                },
                {
                    "facility": "Mog001 20223",
                    "status": "RECRUITING",
                    "city": "Koriyama",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 37.4,
                        "lon": 140.38333
                    }
                },
                {
                    "facility": "Mog001 20224",
                    "status": "RECRUITING",
                    "city": "Sendai",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Mog001 20227",
                    "status": "RECRUITING",
                    "city": "Sendai",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Mog001 20070",
                    "status": "RECRUITING",
                    "city": "Shinjuku-ku",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.2946,
                        "lon": 139.57059
                    }
                },
                {
                    "facility": "Mog001 20032",
                    "status": "RECRUITING",
                    "city": "Suita",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.76143,
                        "lon": 135.51567
                    }
                },
                {
                    "facility": "Mog001 20226",
                    "status": "RECRUITING",
                    "city": "Goyang-si",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.65639,
                        "lon": 126.835
                    }
                },
                {
                    "facility": "Mog001 20104",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Mog001 50485",
                    "status": "RECRUITING",
                    "city": "Ciudad de Mexico",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Mog001 50486",
                    "status": "RECRUITING",
                    "city": "Culiac\u00e1n",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 24.79032,
                        "lon": -107.38782
                    }
                },
                {
                    "facility": "Mog001 40669",
                    "status": "RECRUITING",
                    "city": "Porto",
                    "country": "Portugal",
                    "geoPoint": {
                        "lat": 41.14961,
                        "lon": -8.61099
                    }
                },
                {
                    "facility": "Mog001 40267",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Mog001 40100",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Mog001 40161",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Mog001 40660",
                    "status": "RECRUITING",
                    "city": "Gothenburg",
                    "country": "Sweden",
                    "geoPoint": {
                        "lat": 57.70716,
                        "lon": 11.96679
                    }
                },
                {
                    "facility": "Mog001 40663",
                    "status": "RECRUITING",
                    "city": "Huddinge",
                    "country": "Sweden",
                    "geoPoint": {
                        "lat": 59.23705,
                        "lon": 17.98192
                    }
                },
                {
                    "facility": "Mog001 40723",
                    "status": "RECRUITING",
                    "city": "Basel",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 47.55839,
                        "lon": 7.57327
                    }
                },
                {
                    "facility": "Mog001 40337",
                    "status": "RECRUITING",
                    "city": "Bern",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 46.94809,
                        "lon": 7.44744
                    }
                },
                {
                    "facility": "Mog001 20096",
                    "status": "RECRUITING",
                    "city": "Changhua County,changhua CITY",
                    "country": "Taiwan"
                },
                {
                    "facility": "Mog001 20303",
                    "status": "RECRUITING",
                    "city": "Kaohsuing CITY",
                    "country": "Taiwan"
                },
                {
                    "facility": "Mog001 20080",
                    "status": "RECRUITING",
                    "city": "Taichung City",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Mog001 20094",
                    "status": "RECRUITING",
                    "city": "Tainan City",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "Mog001 20304",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Mog001 20082",
                    "status": "RECRUITING",
                    "city": "Taoyuan City",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                },
                {
                    "facility": "Mog001 40726",
                    "status": "RECRUITING",
                    "city": "Izmir",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 38.41273,
                        "lon": 27.13838
                    }
                },
                {
                    "facility": "Mog001 40550",
                    "status": "RECRUITING",
                    "city": "\u0130\u0307stanbul",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Mog001 40648",
                    "status": "RECRUITING",
                    "city": "Samsun",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.27976,
                        "lon": 36.3361
                    }
                },
                {
                    "facility": "Mog001 40725",
                    "status": "RECRUITING",
                    "city": "Sancaktepe",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.00244,
                        "lon": 29.23187
                    }
                },
                {
                    "facility": "Mog001 20228",
                    "status": "RECRUITING",
                    "city": "Ternopil",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 49.55589,
                        "lon": 25.60556
                    }
                },
                {
                    "facility": "Mog001 40661",
                    "status": "RECRUITING",
                    "city": "Liverpool",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.41058,
                        "lon": -2.97794
                    }
                },
                {
                    "facility": "Mog001 40163",
                    "status": "RECRUITING",
                    "city": "Oxford",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.75222,
                        "lon": -1.25596
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35674086",
                    "type": "DERIVED",
                    "citation": "Mader S, Kumpfel T, Meinl E. Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond. Curr Opin Neurol. 2022 Jun 1;35(3):427-435. doi: 10.1097/WCO.0000000000001052."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Data from this trial may be requested by qualified researchers six months after product approval in the US and/or Europe, or global development is discontinued, and 18 months after trial completion. Investigators may request access to anonymized individual patient-level data and redacted trial documents which may include: analysis-ready datasets, study protocol, annotated case report form, statistical analysis plan, dataset specifications, and clinical study report. Prior to use of the data, proposals need to be approved by an independent review panel at www.Vivli.org and a signed data sharing agreement will need to be executed. All documents are available in English only, for a prespecified time, typically 12 months, on a password protected portal. This plan may change if the risk of re-identifying trial participants is determined to be too high after the trial is completed; in this case and to protect participants, individual patient-level data would not be made available.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "Data from this trial may be requested by qualified researchers six months after product approval in the US and/or Europe or global development is discontinued, and 18 months after trial completion.",
            "accessCriteria": "Qualified researchers may request access to anonymized IPD and redacted study documents which may include: raw datasets, analysis-ready datasets, study protocol, blank case report form, annotated case report form, statistical analysis plan, dataset specifications, and clinical study report. Prior to use of the data, proposals need to be approved by an independent review panel at www.Vivli.org and a signed data sharing agreement will need to be executed.All documents are available in English only, for a pre-specified time, typically 12 months, on a password protected portal.",
            "url": "http://www.Vivli.org"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000627812",
                    "term": "Rozanolixizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4854",
                    "name": "Benzocaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M287616",
                    "name": "Rozanolixizumab",
                    "asFound": "CMV infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M340819",
                    "name": "polysaccharide-K",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "T433",
                    "name": "Tannic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}